Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

Andrea De Luca, J. E. Swartz, L. Vandekerckhove, H. Ammerlaan, A. C. De Vries, J. Begovac, W. F.W. Bierman, C. A.B. Boucher, M. E. Van Der Ende, Z. Grossman, R. Kaiser, I. Levy, T. Mudrikova, R. Paredes, D. Perez-Bercoff, M. Pronk, C. Richter, J. C. Schmit, J. Vercauteren, M. ZazziS. Židovec Lepej, A. M.J. Wensing

Risultato della ricerca: Contributo in rivistaArticolo in rivista

9 Citazioni (Scopus)

Abstract

The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.
Lingua originaleEnglish
pagine (da-a)1850-1857
Numero di pagine8
RivistaJournal of Antimicrobial Chemotherapy
Volume70
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • HIV-1
  • co-formulation
  • first-line antiretroviral therapy

Fingerprint Entra nei temi di ricerca di 'Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe'. Insieme formano una fingerprint unica.

Cita questo